Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Net revenue $ 235,097 $ 289,429
Operating expenses:    
Cost of sales [1] 57,467 72,716
Selling and marketing 55,475 64,623
Research and development 58,376 67,683
General and administrative 45,859 46,121
Depreciation and amortization 38,360 45,440
Restructuring and related 3,482 25,710
Total operating costs and expenses 259,019 322,293
Loss from operations (23,922) (32,864)
Other income (expense), net:    
Change in fair value of warrant liabilities 156 856
Change in fair value of contingent consideration (4,968) (85)
Interest income, net 2,943 4,902
Other expense, net (910) (97)
Total other (loss) income, net (2,779) 5,576
Loss before income taxes (26,701) (27,288)
Income tax expense (1,938) (1,399)
Net loss $ (28,639) $ (28,687)
Net loss attributable to common stockholders per share:    
Basic (USD per share) $ (0.23) $ (0.22)
Diluted (USD per share) $ (0.23) $ (0.22)
Weighted average shares of common stock outstanding:    
Basic (shares) 125,679 129,438
Diluted (shares) 125,679 129,438
[1] Amounts exclude depreciation and amortization.